You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Exercise Disclosure
Baynes Roy D. · SEC Form 4 · Filed Jun 16, 2026
Exercise
Calculated transaction value
$96.21K
Baynes Roy D. Director
TVTX
Travere Therapeutics
TVTX
Transaction date
Jun 12, 2026
Public filing date
Jun 16, 2026
Filing lag
Filed 4 days later
TVTX daily price context
Close on/before transaction
$52.04
Jun 12, 2026
First close after public filing
$54.14
Jun 17, 2026
30-day return after filing
+2.11%
Through Jul 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,500 shares @ $21.38
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001680739-26-000014
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$321.21K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX Current | Exercise | Jun 12, 2026 | $96.21K |
| Travere Therapeutics, Inc. TVTX | Sale | Jun 12, 2026 | $225K |
| Travere Therapeutics, Inc. TVTX | Exercise | Jun 12, 2026 | $0 |